Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Performance
Open
3.65Prev. Close
3.65Volume
0Total traded value
NAUpper Circuit
3.65Lower Circuit
3.47Fundamentals
| Market Cap | ₹1.56Cr |
| ROE | 6.97% |
| P/E Ratio(TTM) | -5.37 |
| EPS(TTM) | -0.68 |
| P/B Ratio | 0.00 |
| Dividend Yield | 0.00% |
| Industry P/E | 41.14 |
| Book Value | -6.07 |
| Debt to Equity | -0.92 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Cresanto Global
Raymed Labs is a pharmaceutical company engaged in manufacturing, trading, and distributing a wide range of medical, chemical, veterinary, and human medicine products. The company's core philosophy is to foster an environment of fairness, equity, and transparency to secure long-term value for all stakeholders. In the 2023-24 financial year, the company successfully reduced its net loss from Rs. 17.09 lakh to Rs. 10.16 lakh.;
| Parent Organisation | Cresanto Global |
| BSE Symbol | 531207 |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 61.77 | ||
| Gland Pharma | NA (0.00%) | 43.16 | ||
| Ajanta Pharma | NA (0.00%) | 34.11 | ||
| Eris Lifesciences | NA (0.00%) | 57.80 |